Who are the peers of the Piramal Pharma?

Peers: The peers of Piramal Pharma are Cohance Life, Ipca Labs, Ajanta Pharma, Gland Pharma, Wockhardt, J B Chemicals &, Emcure Pharma, Pfizer, and ERIS Lifescience.
Quality Snapshot: Excellent management risk is observed at Cohance Life and Ajanta Pharma, while Good management risk is found at Ipca Labs, Gland Pharma, J B Chemicals &, Emcure Pharma, and Pfizer. Average management risk is present at Wockhardt and Piramal Pharma. Below Average management risk is noted at none of the peers. In terms of Growth, Excellent growth is seen at Piramal Pharma, while Good growth is observed at Wockhardt, Average growth is found at Ipca Labs, J B Chemicals &, and the rest, while Below Average growth is noted at Cohance Life, Ajanta Pharma, Gland Pharma, Emcure Pharma, Pfizer, and ERIS Lifescience. For Capital Structure, Excellent capital structure is present at Cohance Life, Ipca Labs, Ajanta Pharma, Gland Pharma, J B Chemicals &, and Pfizer, while Good capital structure is noted at Emcure Pharma, and Below Average capital structure is observed at Wockhardt and Piramal Pharma.

Return Snapshot: The peer with the highest 1-year return is Wockhardt at 116.70%, while the peer with the lowest is J B Chemicals & at -7.94%. Piramal Pharma's 1-year return of 40.51% is significantly higher than J B Chemicals & but lower than Wockhardt. Additionally, the peers with negative six-month returns include Piramal Pharma, J B Chemicals &, and Emcure Pharma.